Literature DB >> 1486887

Variability of surface-exposed antigens of different strains of Moraxella catarrhalis.

I Jönsson1, T Holme, A Krook, M Rahman, M Thorén.   

Abstract

For serological diagnosis of infection with Moraxella (Branhamella) catarrhalis it is important to determine if there is variability of antigenic properties among different strains. Cross-reactions of nine strains were investigated by an immunofluorescence test using sera from immunized rabbits. All titres but one were 1:256 or higher, the highest being 1:4096. Thus a high degree of antigenic similarity was demonstrated among different strains of Moraxella catarrhalis. However, the homologous titres of six sera were 2 to 16 times higher than the titres for other strains indicating strain variations in antigenic properties of some surface components. There was no correlation between lipopolysaccharide type and titre in the immunofluorescence test.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486887     DOI: 10.1007/bf01962374

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M Van Den Abeele
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  An enzyme-linked immunosorbent assay for the determination of human IgG subclass antibodies directed against Branhamella catarrhalis.

Authors:  D Goldblatt; N D Seymour; R J Levinsky; M W Turner
Journal:  J Immunol Methods       Date:  1990-04-17       Impact factor: 2.303

3.  Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Authors:  K Groeneveld; L van Alphen; C Voorter; P P Eijk; H M Jansen; H C Zanen
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

Review 4.  Branhamella catarrhalis--an emerging human pathogen.

Authors:  G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

5.  Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy; L C Bartos
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

Review 6.  Studies of the outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

7.  Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae.

Authors:  E M Haase; A A Campagnari; J Sarwar; M Shero; M Wirth; C U Cumming; T F Murphy
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

8.  Serological identification of Branhamella catarrhalis. Serological evidence for infection.

Authors:  I Eliasson
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis.

Authors:  M Leinonen; J Luotonen; E Herva; K Valkonen; P H Mäkelä
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

10.  Development of bactericidal antibody during Branhamella catarrhalis infection.

Authors:  A J Chapman; D M Musher; S Jonsson; J E Clarridge; R J Wallace
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  7 in total

1.  Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.

Authors:  Katie J Edwards; Johanna M Schwingel; Anup K Datta; Anthony A Campagnari
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.

Authors:  Katie J Edwards; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

3.  Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria.

Authors:  I Jönsson; T Holme; A Krook; M Thorén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

4.  A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides.

Authors:  K Oishi; H Tanaka; F Sonoda; S Borann; K Ahmed; Y Utsunomiya; K Watanabe; T Nagatake; M Vaneechoutte; G Verschraegen; K Matsumoto
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

5.  Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection.

Authors:  M Rahman; T Holme; I Jönsson; A Krook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

6.  Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

Authors:  M E Helminen; R Beach; I Maciver; G Jarosik; E J Hansen; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

7.  Maternal antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay.

Authors:  T Ejlertsen; E Thisted; P A Ostergaard; J Renneberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.